All Type of News
“The selling restriction of generics can cause the social benefit cost worth between KRW 2.4 billion and KRW 4.1 billion”
As the Patent Linkage System will be fully enforced on 15th next month, it is analyzed that companies having original products will get reflected benefits worth of KRW 3.2 billion at most every year through the newly ...
Celltrion unveiled various clinical study results of ‘Remsima’ in EuropeAt the European Crohn’s and Colitis Organization (ECCO)that has been held at Barcelona, Spain, since 18 February, Celltrion unveiled the result of 6 researches to targetinflamma...
|
.jpg)
Foggy psychological warfare between Green Cross and Ildong Pharmaceutical regarding M&AIt seems that conflictstriggeredby the Green Cross’s ‘Shareholder Proposal’between Green Cross and Ildong Pharmaceutical will be prolonged.
Ildong Pharmaceutical (CEO Jung-chi ...
|
Kwang Dong and Jeil has newly entered KRW 500 billion sales… there are now 8 companies in total
The top 2 pharmaceuticalcompanies, Kwang Dong Pharmaceutical and Jeil Pharmaceutical, had newly entered KRW 500 billion sales in 2014. Therefore, there are now the total 8 companies exceeding KRW 500 billion sales: Yu...
Handok recorded the lowest price again among generics of Sevikar after BaracludeHandokTevahas triggeredcompetition for the lowest generic price in this early year.Followed by the chronic hepatitis type B treatment, Baraclude, it is now generics of the hyper...
|
Xeljanx, the oral rheumarthritis drug, will receive the insurance benefit from this MarchIt will now be available to manage rheumarthritisonly with oral drugs2 times.
The Ministry of Health and Welfare had made an administrative notice for the amendment of ‘details...
|
There are more products having deficits than ones with surpluses on the Chinese importation and exportation
It is known that the product that has made the largest profits on exports to China was blood or serum material products.
According to the ‘exportation and importation record’revealed bythe Korea Health Industry Devel...
Green Cross has sent the official announcementregardingits position of the ‘Shareholder Proposal’ to Ildong PharmaceuticalIt is observed that Green Cross has sent an official announcement to Ildong Pharmaceutical on the 16th.
Green Cross has not mentioned about ‘M&A’ in the official announcement a...
|
The KRPIA stated “The Drug Price Policy lowers values of new drugs”The Korean Research-based Pharma Industry Association (KRPIA) spoke that it turned in a written opinion to the Ministry of Health and Welfare on the 16thin regards to the ‘Parti...
|
Chong Kun Dang will conduct joint marketing with Allergan Korea on eye disease treatmentsChong Kun Dang (CEO Jung-woo Kim)had an agreement ceremony at Grand Hyatt Seoul on the 13thfor joint marketing with Allergan Korea over two types of eye drops for ophthalmologic...
|
.jpg)
